Bostwick Laboratories Income Statement
View: Annual
| Dec 07 | Dec 06 | Dec 05 | |
|---|---|---|---|
| Revenue | 102.8 | 58.4 | 30.3 |
| Cost of Goods Sold | 38.9 | 21.1 | 12.8 |
| Gross Profit | 63.9 | 37.3 | 17.5 |
| Gross Profit Margin | 62.1% | 63.8% | 57.8% |
| SG&A Expense | 56.1 | 25.9 | 16.9 |
| Depreciation & Amortization | -- | 1.7 | 1.2 |
| Operating Income | 7.8 | 11.4 | 0.6 |
| Operating Margin | 7.5% | 19.5% | 1.9% |
| Nonoperating Income | 0.8 | 0.0 | 0.0 |
| Nonoperating Expenses | 2.6 | 0.4 | 0.4 |
| Income Before Taxes | 6.0 | 11.0 | 0.2 |
| Income Taxes | 3.7 | 3.9 | 0.2 |
| Net Income After Taxes | 2.3 | 7.1 | 0.1 |
| Continuing Operations | 2.3 | 7.1 | 0.1 |
| Discontinued Operations | 0.0 | 0.0 | 0.0 |
| Total Operations | 2.3 | 7.1 | 0.1 |
| Total Net Income | 2.3 | 7.1 | 0.1 |
| Net Profit Margin | 2.2% | 12.1% | 0.2% |
| Diluted EPS from Total Net Income ($) | -- | -- | -- |
| Dividends per Share | -- | -- | -- |
